Back to search

Article

Tumor DNA from tumor in situ fluid was used to track genomic status and evolutionary models of gliomas under first-line treatment

2022-04-08

Abstract excerpt

<h4>Background: </h4> Tumor DNA from tumor in situ fluid (TISF) provides a minimally invasive approach to repeatedly interrogated the glioma genome and provides an opportunity to monitor the dynamics of pressure-induced cloning for recurrence and treatment selectivity. Understanding the evolution of glioma will be of great help in clinical and scientific research of glioma. Currently, no study has explored the rec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f55a58a4-8806-54fb-b6fe-399dc7cb7a7a
DOI
10.21203/rs.3.rs-1422136/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tumor DNA from tumor in situ fluid was used to track genomic status and evolutionary models of gliomas under first-line treatmentDOI 10.21203/rs.3.rs-1422136/v2
Select a neighboring publication to make it the new centre.